These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 669885)

  • 1. Synthesis of some new analogs of the immunoadjuvant glycopeptide MDP (N-acetyl-muramyl-L-alanyl-D-isoglutamine).
    Lefrancier P; Derrien M; Lederman I; Nief F; Choay J; Lederer E
    Int J Pept Protein Res; 1978 Apr; 11(4):289-96. PubMed ID: 669885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of N-acetyl-muramyl-L-alanyl-D-isoglutamine, an adjuvant of the immune response, and of some n-acetyl-muramyl-peptide analogs.
    Lefrancier P; Choay J; Derrien M; Lederman I
    Int J Pept Protein Res; 1977; 9(4):249-57. PubMed ID: 852928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of carbohydrate analogs (positional, configurational, and optical) of n-acetylmuramoyl-L-alanyl-D-isoglutamine, and their immunoadjuvant activities.
    Hasegawa A; Kaneda Y; Goh Y; Nishibori K; Kiso M; Azuma I
    Carbohydr Res; 1981 Aug; 94(2):143-63. PubMed ID: 7273036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-specific MIF-like activity induced by the synthetic immunoadjuvant: N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP).
    Adam A; Souvannavong V; Lederer E
    Biochem Biophys Res Commun; 1978 Nov; 85(2):684-90. PubMed ID: 367370
    [No Abstract]   [Full Text] [Related]  

  • 5. N-acetyl muramyl dipeptide stimulation of bone resorption in tissue culture.
    Dewhirst FE
    Infect Immun; 1982 Jan; 35(1):133-7. PubMed ID: 7054120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Heymer B; Finger H; Wirsing CH
    Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of binding of MDP, a synthetic immunoadjuvant, to anti-peptidoglycan antibodies.
    Audibert F; Heymer B; Gros C; Schleifer KH; Seidl PH; Chedid L
    J Immunol; 1978 Oct; 121(4):1219-22. PubMed ID: 701793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical synthesis and adjuvant activity of N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) analogs 1, 2.
    Kamisango K; Saiki I; Tanio Y; Kobayashi S; Fukuda T; Sekikawa I; Azuma I; Yamamura Y
    Chem Pharm Bull (Tokyo); 1981 Jun; 29(6):1644-54. PubMed ID: 7296716
    [No Abstract]   [Full Text] [Related]  

  • 9. Higher immunoadjuvant activities of N-acetyl-beta-D-glucosaminyl-(1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine in comparison with N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Tsujimoto M; Kinoshita F; Okunaga T; Kotani S; Kusumoto S; Yamamoto K; Shiba T
    Microbiol Immunol; 1979; 23(9):933-6. PubMed ID: 576117
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlation between in vivo anti-Pseudomonas and anti-Candida activities and clearance of carbon by the reticuloendothelial system for various muramyl dipeptide analogs, using normal and immunosuppressed mice.
    Fraser-Smith EB; Waters RV; Matthews TR
    Infect Immun; 1982 Jan; 35(1):105-10. PubMed ID: 7054119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical modification of the C-6 substituent in the carbohydrate moiety of N-acetylmuramoyl-L-alanyl-D-isoglutamine (MDP), and the immunoadjuvant activity.
    Okumura H; Tokushima Y; Saiki I; Azuma I; Kiso M; Hasegawa A
    Carbohydr Res; 1983 Oct; 122(1):87-98. PubMed ID: 6652634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and immunoadjuvant activities of muramoyl-L-alanyl-D-isoglutamine and some carbohydrate analogs.
    Kiso M; Kaneda Y; Okumura H; Hasegawa A; Azuma I; Yamamura Y
    Carbohydr Res; 1980 Feb; 79(1):C17-9. PubMed ID: 7357566
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis of immunologically active muramyl dipeptide derivatives containing a quinonyl moiety via aminoacyl intermediates.
    Fukuda T; Kobayashi S; Yukimasa H; Imada I; Fujino M; Azuma I; Yamamura Y
    Chem Pharm Bull (Tokyo); 1981 Aug; 29(8):2215-21. PubMed ID: 7318034
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis of N-acetyl-muramyl-L-alanyl-D-glutamic-alpha-amide(MDP) or -alpha-methyl ester derivatives, bearing a lipophilic group at the C-terminal peptide end.
    Lefrancier P; Petitou M; Level M; Derrien M; Choay J; Lederer E
    Int J Pept Protein Res; 1979; 14(5):437-44. PubMed ID: 536111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Synthesis of N-acetyl-muramyl-dipeptide--an immunoadjuvant].
    Chen ZY; Chen LF; Gong XQ
    Yao Xue Xue Bao; 1982 Jun; 17(6):425-30. PubMed ID: 7148465
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis and immunoadjuvant activities of 2-acetamido-5-O-acetyl-6-O-acyl-2-deoxy-3-O-[(R)-2-propionyl-L-alanyl-D- isoglutamine]-D-glucofuranoses as potential prodrug forms of 6-O-Acyl Derivatives of N-acetylmuramyl dipeptide.
    Durette PL; Dorn CP; Friedman A; Schlabach A
    J Med Chem; 1982 Sep; 25(9):1028-33. PubMed ID: 7131480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A shortened synthesis of adjuvant dipeptide (MDP).
    Schwartzman SM; Ribi E
    Prep Biochem; 1980; 10(3):255-67. PubMed ID: 7413603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonspecific activation of murine spleen cells in vitro by a synthetic immunoadjuvant (N-acetyl-muramyl-L-alanyl-D-isoglutamine).
    Damais C; Parant M; Chedid L
    Cell Immunol; 1977 Nov; 34(1):49-56. PubMed ID: 562238
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro spleen cell responsiveness to various analogs of MDP (N-acetylmuramyl-L-alanyl-D-isoglutamine), a synthetic immunoadjuvant, in MDP high-responder mice.
    Damais C; Parant M; Chedid L; Lefrancier P; Choay J
    Cell Immunol; 1978 Jan; 35(1):173-9. PubMed ID: 563773
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship between chemical structure and adjuvant activity of some synthetic analogues of N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDP).
    Audibert F; Chedid L; Lefrancier P; Choay J; Lederer E
    Ann Immunol (Paris); 1977; 128C(3):653-61. PubMed ID: 869513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.